| NCT04459897 |
Lyon Granulomatous Hepatitis Study |
https://ClinicalTrials.gov/show/NCT04459897 |
Recruiting |
Hospices Civils de Lyon |
2023-01-01 |
| NCT03396458 |
Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg |
https://ClinicalTrials.gov/show/NCT03396458 |
Recruiting |
Hasselt University |
2020-08-31 |
| NCT03566563 |
Epidemiology of Chronic Hepatitis C and Disease Modelling |
https://ClinicalTrials.gov/show/NCT03566563 |
Recruiting |
Changi General Hospital |
2019-02-18 |
| NCT03366610 |
Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens |
https://ClinicalTrials.gov/show/NCT03366610 |
Completed |
Bristol-Myers Squibb |
2019-04-30 |
| NCT03825458 |
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. |
https://ClinicalTrials.gov/show/NCT03825458 |
Recruiting |
Hospices Civils de Lyon |
2022-10-31 |
| NCT03358108 |
A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study) |
https://ClinicalTrials.gov/show/NCT03358108 |
Recruiting |
Tongji Hospital |
2020-12-01 |
| NCT03341871 |
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6 |
https://ClinicalTrials.gov/show/NCT03341871 |
Active, not recruiting |
AbbVie |
2020-12-31 |
| NCT03329820 |
Quality of Life and Health Utility of Patients With CHB Infections |
https://ClinicalTrials.gov/show/NCT03329820 |
Completed |
The University of Hong Kong |
2009-06-30 |
| NCT03318887 |
Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA |
https://ClinicalTrials.gov/show/NCT03318887 |
Completed |
Hospices Civils de Lyon |
2014-09-30 |
| NCT03316313 |
Hepatitis C Screening in the Primary Care Setting |
https://ClinicalTrials.gov/show/NCT03316313 |
Completed |
New York Institute of Technology |
2016-10-31 |
| NCT03313154 |
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related |
https://ClinicalTrials.gov/show/NCT03313154 |
Completed |
Azienda Ospedaliero Universitaria di Cagliari |
2018-07-31 |
| NCT03303599 |
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6 |
https://ClinicalTrials.gov/show/NCT03303599 |
Completed |
AbbVie |
2020-01-24 |
| NCT03300414 |
Biologic Basis of Liver Cancer From Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03300414 |
Completed |
University of California, Davis |
2018-12-14 |
| NCT03290755 |
Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux |
https://ClinicalTrials.gov/show/NCT03290755 |
Completed |
University Hospital, Bordeaux |
2018-03-13 |
| NCT03254121 |
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response |
https://ClinicalTrials.gov/show/NCT03254121 |
Recruiting |
Karolinska Institutet |
2021-01-01 |
| NCT03248622 |
Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT03248622 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-05-28 |
| NCT03246048 |
Long Term Follow-up of Hepatitis C Cured Patients |
https://ClinicalTrials.gov/show/NCT03246048 |
Active, not recruiting |
Hospital Universitari Vall d’Hebron Research Institute |
2021-01-31 |
| NCT03245931 |
Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1 |
https://ClinicalTrials.gov/show/NCT03245931 |
Completed |
TriHealth Inc. |
2019-08-26 |
| NCT03215732 |
Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal |
https://ClinicalTrials.gov/show/NCT03215732 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2019-07-31 |
| NCT03201718 |
A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs |
https://ClinicalTrials.gov/show/NCT03201718 |
Completed |
AbbVie |
2019-10-11 |
| NCT03200379 |
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan |
https://ClinicalTrials.gov/show/NCT03200379 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2037-06-15 |
| NCT03200171 |
Effect of DAAs on Behavior of HCC in HCV Patients |
https://ClinicalTrials.gov/show/NCT03200171 |
Recruiting |
Al-Azhar University |
2019-08-31 |
| NCT03186235 |
T Regulatory Cells in Hepatitis c Infected Patients |
https://ClinicalTrials.gov/show/NCT03186235 |
Completed |
Assiut University |
2019-08-01 |
| NCT03181074 |
Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults |
https://ClinicalTrials.gov/show/NCT03181074 |
Completed |
Bristol-Myers Squibb |
2019-08-19 |
| NCT03158818 |
Chronic Hepatitis B Virus Infection in Zambia |
https://ClinicalTrials.gov/show/NCT03158818 |
Recruiting |
University of Alabama at Birmingham |
2021-01-31 |
| NCT03149627 |
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults |
https://ClinicalTrials.gov/show/NCT03149627 |
Completed |
University of Alabama at Birmingham |
2018-12-19 |
| NCT03149289 |
Hepatitis C Virus Infection in Patients With Hemoglobinopathies |
https://ClinicalTrials.gov/show/NCT03149289 |
Completed |
Società Italiana Talassemie ed Emoglobinopatie |
2016-03-01 |
| NCT03145844 |
Direct Acting Agents in Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT03145844 |
Completed |
Viral Hepatitis Society |
2018-12-31 |
| NCT03144440 |
Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel |
https://ClinicalTrials.gov/show/NCT03144440 |
Active, not recruiting |
Carmel Medical Center |
2020-01-01 |
| NCT03122132 |
Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks |
https://ClinicalTrials.gov/show/NCT03122132 |
Completed |
Hepa C |
2018-01-01 |
| NCT03109457 |
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03109457 |
Completed |
Cairo University |
2018-02-07 |
| NCT03088995 |
Pilot Study of HIV and Hepatitis B and C Screening in Surgery |
https://ClinicalTrials.gov/show/NCT03088995 |
Completed |
Centre de Recherches et d’Etude sur la Pathologie Tropicale et le Sida |
2017-09-01 |
| NCT03088917 |
‘Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat’ |
https://ClinicalTrials.gov/show/NCT03088917 |
Completed |
Radboud University |
2019-12-01 |
| NCT03042481 |
Off-therapy Response After Stopping Entecavir or Tenofovir |
https://ClinicalTrials.gov/show/NCT03042481 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2019-05-31 |
| NCT03063723 |
Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs |
https://ClinicalTrials.gov/show/NCT03063723 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2016-12-01 |
| NCT03038763 |
Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers |
https://ClinicalTrials.gov/show/NCT03038763 |
Completed |
University of Pennsylvania |
2019-06-30 |
| NCT03053180 |
Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation |
https://ClinicalTrials.gov/show/NCT03053180 |
Completed |
AbbVie |
2017-12-18 |
| NCT03000023 |
Anticipated and Perceived Benefits Following Hepatitis C Treatment |
https://ClinicalTrials.gov/show/NCT03000023 |
Completed |
University of North Carolina, Chapel Hill |
2018-07-31 |
| NCT02995252 |
The HOPE Study: Characterizing Patients With Hepatitis B and C |
https://ClinicalTrials.gov/show/NCT02995252 |
Recruiting |
University of Maryland, Baltimore |
2020-01-31 |
| NCT03002818 |
Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®) |
https://ClinicalTrials.gov/show/NCT03002818 |
Completed |
AbbVie |
2018-04-25 |
| NCT02994537 |
Study of the Clinical Features of Autoimmune Hepatitis |
https://ClinicalTrials.gov/show/NCT02994537 |
Recruiting |
West China Hospital |
2019-10-02 |
| NCT02985450 |
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada |
https://ClinicalTrials.gov/show/NCT02985450 |
Recruiting |
University of Calgary |
2019-12-31 |
| NCT02982993 |
Hepatitis C Infection in World Trade Center Responders |
https://ClinicalTrials.gov/show/NCT02982993 |
Completed |
Icahn School of Medicine at Mount Sinai |
2018-07-12 |
| NCT02196064 |
Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the “The HEPAVIR HEPATIC SAFETY Cohort.” |
https://ClinicalTrials.gov/show/NCT02196064 |
Completed |
Andalusian Network for Design and Translation of Advanced Therapies |
2015-07-31 |
| NCT02945228 |
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2 |
https://ClinicalTrials.gov/show/NCT02945228 |
Completed |
AbbVie |
2019-07-26 |
| NCT02909023 |
Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured |
https://ClinicalTrials.gov/show/NCT02909023 |
Completed |
Hospices Civils de Lyon |
2016-09-30 |
| NCT02907996 |
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea |
https://ClinicalTrials.gov/show/NCT02907996 |
Recruiting |
Gilead Sciences |
2021-09-30 |
| NCT02881034 |
Ribavirin Bioavailability After Telaprevir Exposure |
https://ClinicalTrials.gov/show/NCT02881034 |
Completed |
Hospices Civils de Lyon |
2015-02-28 |
| NCT02877199 |
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy |
https://ClinicalTrials.gov/show/NCT02877199 |
Completed |
Hospices Civils de Lyon |
2015-04-30 |
| NCT02876419 |
A Long Term Follow-up Study of Patients From the REP 301 Protocol |
https://ClinicalTrials.gov/show/NCT02876419 |
Active, not recruiting |
Replicor Inc. |
2019-11-13 |
| NCT02863757 |
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02863757 |
Recruiting |
Humanity and Health Research Centre |
2026-12-31 |
| NCT02847507 |
Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb) |
https://ClinicalTrials.gov/show/NCT02847507 |
Completed |
Centre Hospitalier de la côte Basque |
2018-01-31 |
| NCT02851069 |
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia |
https://ClinicalTrials.gov/show/NCT02851069 |
Completed |
AbbVie |
2018-08-30 |
| NCT02817594 |
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02817594 |
Completed |
AbbVie |
2018-03-07 |
| NCT02807402 |
Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania |
https://ClinicalTrials.gov/show/NCT02807402 |
Completed |
AbbVie |
2017-08-04 |
| NCT02799355 |
Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium |
https://ClinicalTrials.gov/show/NCT02799355 |
Completed |
Dayanand Medical College and Hospital |
2016-09-30 |
| NCT02803138 |
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02803138 |
Completed |
AbbVie |
2018-10-21 |
| NCT02798315 |
Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study |
https://ClinicalTrials.gov/show/NCT02798315 |
Completed |
AbbVie |
2017-06-12 |
| NCT02796469 |
Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT02796469 |
Completed |
University Hospital, Lille |
2016-05-31 |
| NCT02791386 |
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT02791386 |
Completed |
Bristol-Myers Squibb |
2017-10-30 |
| NCT02785835 |
Hepatocellular Carcinoma in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT02785835 |
Recruiting |
Hospital Universitario de Valme |
2016-12-31 |
| NCT02773394 |
Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil |
https://ClinicalTrials.gov/show/NCT02773394 |
Completed |
Janssen-Cilag Ltd. |
2016-11-30 |
| NCT02749864 |
Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) |
https://ClinicalTrials.gov/show/NCT02749864 |
Completed |
Instituto de Investigación Marqués de Valdecilla |
2017-04-01 |
| NCT02726022 |
A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels |
https://ClinicalTrials.gov/show/NCT02726022 |
Completed |
Hoffmann-La Roche |
2011-07-31 |
| NCT02725866 |
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02725866 |
Completed |
AbbVie |
2017-10-31 |
| NCT02718573 |
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood |
https://ClinicalTrials.gov/show/NCT02718573 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-12-11 |
| NCT02669940 |
Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation |
https://ClinicalTrials.gov/show/NCT02669940 |
Completed |
AbbVie |
2017-07-04 |
| NCT02650024 |
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes |
https://ClinicalTrials.gov/show/NCT02650024 |
Recruiting |
University of California, San Diego |
2020-07-31 |
| NCT02647879 |
Treatment as Prevention for Hepatitis C in Iceland |
https://ClinicalTrials.gov/show/NCT02647879 |
Recruiting |
Landspitali University Hospital |
2020-12-31 |
| NCT02640547 |
Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02640547 |
Completed |
AbbVie |
2017-03-29 |
| NCT02636608 |
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary |
https://ClinicalTrials.gov/show/NCT02636608 |
Completed |
AbbVie |
2018-05-23 |
| NCT02629172 |
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1 |
https://ClinicalTrials.gov/show/NCT02629172 |
Completed |
AbbVie |
2019-02-28 |
| NCT02618928 |
The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France |
https://ClinicalTrials.gov/show/NCT02618928 |
Completed |
AbbVie |
2018-03-29 |
| NCT02615145 |
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C) |
https://ClinicalTrials.gov/show/NCT02615145 |
Completed |
AbbVie |
2018-03-26 |
| NCT02597790 |
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects |
https://ClinicalTrials.gov/show/NCT02597790 |
Completed |
University of California, Los Angeles |
2019-01-31 |
| NCT02597270 |
An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection |
https://ClinicalTrials.gov/show/NCT02597270 |
Completed |
Janssen-Cilag Ltd. |
2016-11-30 |
| NCT02591277 |
Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02591277 |
Completed |
Gilead Sciences |
2017-11-01 |
| NCT02592057 |
Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India |
https://ClinicalTrials.gov/show/NCT02592057 |
Completed |
Gilead Sciences |
2017-11-30 |
| NCT02582671 |
The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland |
https://ClinicalTrials.gov/show/NCT02582671 |
Completed |
AbbVie |
2017-11-29 |
| NCT02582658 |
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL) |
https://ClinicalTrials.gov/show/NCT02582658 |
Completed |
AbbVie |
2017-01-12 |
| NCT02581189 |
Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada |
https://ClinicalTrials.gov/show/NCT02581189 |
Completed |
AbbVie |
2017-12-20 |
| NCT04356404 |
Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients |
https://ClinicalTrials.gov/show/NCT04356404 |
Recruiting |
Chinese University of Hong Kong |
2022-05-31 |
| NCT00050115 |
Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00050115 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004850 |
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00004850 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01350648 |
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection |
https://ClinicalTrials.gov/show/NCT01350648 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02566148 |
Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France |
https://ClinicalTrials.gov/show/NCT02566148 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2012-02-29 |
| NCT01263600 |
Hepatitis B Research Network Pediatric Cohort Study (HBRN) |
https://ClinicalTrials.gov/show/NCT01263600 |
Active, not recruiting |
University of Pittsburgh |
2020-09-30 |
| NCT01263587 |
Hepatitis B Research Network Adult Cohort Study |
https://ClinicalTrials.gov/show/NCT01263587 |
Active, not recruiting |
University of Pittsburgh |
2020-09-30 |
| NCT02562742 |
Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02562742 |
Completed |
Gilead Sciences |
2017-06-12 |
| NCT02557646 |
An Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02557646 |
Completed |
Hoffmann-La Roche |
2014-03-31 |
| NCT02556307 |
A Study of the Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients |
https://ClinicalTrials.gov/show/NCT02556307 |
Completed |
Hoffmann-La Roche |
2014-07-31 |
| NCT02548325 |
Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study |
https://ClinicalTrials.gov/show/NCT02548325 |
Completed |
Corporacion Parc Tauli |
2015-05-31 |
| NCT02545400 |
Quantification of Side Effects During Hepatitis C Therapy |
https://ClinicalTrials.gov/show/NCT02545400 |
Completed |
Medical University of Graz |
2014-06-30 |
| NCT02537379 |
Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02537379 |
Completed |
Gilead Sciences |
2017-06-05 |
| NCT02545335 |
Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02545335 |
Active, not recruiting |
Medical University of Graz |
2020-12-31 |
| NCT02533544 |
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02533544 |
Completed |
The Catholic University of Korea |
2018-10-31 |
| NCT02531269 |
Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period |
https://ClinicalTrials.gov/show/NCT02531269 |
Completed |
Bristol-Myers Squibb |
2016-02-29 |
| NCT02526641 |
Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02526641 |
Active, not recruiting |
University of Aarhus |
2019-03-31 |
| NCT02528461 |
Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02528461 |
Completed |
University of Aarhus |
2019-01-31 |
| NCT02511743 |
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT02511743 |
Completed |
Peking University First Hospital |
2015-11-30 |
| NCT02508090 |
Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin |
https://ClinicalTrials.gov/show/NCT02508090 |
Completed |
Hoffmann-La Roche |
2017-01-13 |
| NCT02505243 |
Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens |
https://ClinicalTrials.gov/show/NCT02505243 |
Completed |
Radboud University |
2016-06-30 |
| NCT02387463 |
Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02387463 |
Completed |
Beijing Ditan Hospital |
2017-05-21 |
| NCT02368522 |
Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU) |
https://ClinicalTrials.gov/show/NCT02368522 |
Completed |
Bristol-Myers Squibb |
2017-02-28 |
| NCT02366286 |
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants |
https://ClinicalTrials.gov/show/NCT02366286 |
Active, not recruiting |
Mayo Clinic |
2022-12-31 |
| NCT02344498 |
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa |
https://ClinicalTrials.gov/show/NCT02344498 |
Active, not recruiting |
Oslo University Hospital |
2020-12-31 |
| NCT02344680 |
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients |
https://ClinicalTrials.gov/show/NCT02344680 |
Active, not recruiting |
University of Alabama at Birmingham |
2024-08-31 |
| NCT02324218 |
This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age |
https://ClinicalTrials.gov/show/NCT02324218 |
Completed |
GlaxoSmithKline |
2015-01-31 |
| NCT02323308 |
Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination |
https://ClinicalTrials.gov/show/NCT02323308 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2014-06-30 |
| NCT02275221 |
Immune Response in Patients With Hepatitis B and C Infection |
https://ClinicalTrials.gov/show/NCT02275221 |
Recruiting |
Basildon and Thurrock University Hospitals NHS Foundation Trust |
2019-12-31 |
| NCT02275195 |
Immune Cell Dysfunction in Severe Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT02275195 |
Recruiting |
Basildon and Thurrock University Hospitals NHS Foundation Trust |
2019-12-31 |
| NCT02267473 |
Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function |
https://ClinicalTrials.gov/show/NCT02267473 |
Active, not recruiting |
Johann Wolfgang Goethe University Hospital |
2020-10-31 |
| NCT02201407 |
An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study |
https://ClinicalTrials.gov/show/NCT02201407 |
Completed |
Hoffmann-La Roche |
2017-04-10 |
| NCT02190253 |
Seroprevalence of Hepatitis E in People With an Organ Transplant |
https://ClinicalTrials.gov/show/NCT02190253 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-02-05 |
| NCT02172898 |
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium |
https://ClinicalTrials.gov/show/NCT02172898 |
Completed |
Indiana University |
2018-06-29 |
| NCT02167113 |
Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay |
https://ClinicalTrials.gov/show/NCT02167113 |
Completed |
Hologic, Inc. |
2016-02-29 |
| NCT02129829 |
PROLIFICA - West African Treatment Cohort for Hepatitis B |
https://ClinicalTrials.gov/show/NCT02129829 |
Active, not recruiting |
Imperial College London |
2020-04-01 |
| NCT02125071 |
Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02125071 |
Completed |
Seoul St. Mary’s Hospital |
2015-08-31 |
| NCT02112890 |
Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico |
https://ClinicalTrials.gov/show/NCT02112890 |
Completed |
GlaxoSmithKline |
2016-05-02 |
| NCT02108444 |
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT02108444 |
Completed |
Peking University |
2013-12-31 |
| NCT02106156 |
Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists) |
https://ClinicalTrials.gov/show/NCT02106156 |
Completed |
Hoffmann-La Roche |
2013-09-30 |
| NCT02103699 |
A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir |
https://ClinicalTrials.gov/show/NCT02103699 |
Completed |
Janssen Scientific Affairs, LLC |
2015-11-30 |
| NCT02102451 |
Control and Elimination Within Australia of Hepatitis C From People Living With HIV |
https://ClinicalTrials.gov/show/NCT02102451 |
Active, not recruiting |
Kirby Institute |
2020-12-31 |
| NCT02075918 |
Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT02075918 |
Completed |
University of Pittsburgh |
2019-05-31 |
| NCT02075294 |
Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02075294 |
Completed |
Beijing 302 Hospital |
2012-10-31 |
| NCT02069678 |
Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02069678 |
Completed |
Chinese University of Hong Kong |
2013-09-30 |
| NCT02068963 |
Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing |
https://ClinicalTrials.gov/show/NCT02068963 |
Completed |
Hologic, Inc. |
2015-04-30 |
| NCT02065999 |
Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT02065999 |
Recruiting |
Kirby Institute |
2022-04-30 |
| NCT01311947 |
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01311947 |
Completed |
China Medical University Hospital |
2012-03-31 |
| NCT01298037 |
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01298037 |
Active, not recruiting |
University of Pennsylvania |
2021-05-31 |
| NCT01293279 |
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China |
https://ClinicalTrials.gov/show/NCT01293279 |
Completed |
Peking University People’s Hospital |
2011-06-30 |
| NCT01296529 |
Study on Immunopathogenesis in HIV and Hepatitis C Coinfection |
https://ClinicalTrials.gov/show/NCT01296529 |
Completed |
Rush University Medical Center |
2011-12-31 |
| NCT01283074 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) |
https://ClinicalTrials.gov/show/NCT01283074 |
Completed |
Hoffmann-La Roche |
2012-11-30 |
| NCT01280656 |
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION) |
https://ClinicalTrials.gov/show/NCT01280656 |
Completed |
Hoffmann-La Roche |
2012-11-30 |
| NCT01272479 |
Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01272479 |
Completed |
Istanbul University |
2010-03-31 |
| NCT02057003 |
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients |
https://ClinicalTrials.gov/show/NCT02057003 |
Recruiting |
Valme University Hospital |
2020-12-31 |
| NCT02056054 |
De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02056054 |
Recruiting |
Yale University |
2020-05-31 |
| NCT02044055 |
Mother-to-child Hepatitis D Transmission |
https://ClinicalTrials.gov/show/NCT02044055 |
Completed |
Hopital Lariboisière |
2017-04-30 |
| NCT02044523 |
Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound |
https://ClinicalTrials.gov/show/NCT02044523 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2018-06-30 |
| NCT04202081 |
Voices From the Black Community: Hepatitis C Research Participation |
https://ClinicalTrials.gov/show/NCT04202081 |
Completed |
University of North Carolina, Chapel Hill |
2020-05-15 |
| NCT02951364 |
Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea |
https://ClinicalTrials.gov/show/NCT02951364 |
Recruiting |
Gilead Sciences |
2021-10-31 |
| NCT02011932 |
Prospective Observational Study of Disease Progression in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02011932 |
Active, not recruiting |
Beijing YouAn Hospital |
2011-06-30 |
| NCT02006823 |
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02006823 |
Completed |
Duke University |
2014-07-31 |
| NCT02002065 |
The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children |
https://ClinicalTrials.gov/show/NCT02002065 |
Completed |
Sinovac Biotech Co., Ltd |
2013-11-30 |
| NCT02000063 |
Australian Trial in Acute Hepatitis C Recall Study |
https://ClinicalTrials.gov/show/NCT02000063 |
Completed |
Kirby Institute |
2014-03-31 |
| NCT01988753 |
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases |
https://ClinicalTrials.gov/show/NCT01988753 |
Completed |
Baylor College of Medicine |
2016-06-30 |
| NCT01980290 |
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01980290 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2015-02-28 |
| NCT01970254 |
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy |
https://ClinicalTrials.gov/show/NCT01970254 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT01958229 |
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01958229 |
Completed |
National Taiwan University Hospital |
2012-03-31 |
| NCT01953458 |
Therapeutic Option for Hepatitis B and C: a French Cohort |
https://ClinicalTrials.gov/show/NCT01953458 |
Recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2022-08-31 |
| NCT01957618 |
The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy |
https://ClinicalTrials.gov/show/NCT01957618 |
Enrolling by invitation |
National Taiwan University Hospital |
2012-01-31 |
| NCT01918462 |
Protective Immune Mechanisms in Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT01918462 |
Recruiting |
University of Aarhus |
2018-04-30 |
| NCT01921400 |
The Pathogenesis of Hepatitis C Virus Vertical Transmission |
https://ClinicalTrials.gov/show/NCT01921400 |
Completed |
University of North Carolina, Chapel Hill |
2017-12-31 |
| NCT01855997 |
A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue |
https://ClinicalTrials.gov/show/NCT01855997 |
Completed |
Hoffmann-La Roche |
2014-11-28 |
| NCT01850745 |
Multidisciplinary Support Program in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01850745 |
Completed |
Parc de Salut Mar |
2009-01-31 |
| NCT01838070 |
Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U) |
https://ClinicalTrials.gov/show/NCT01838070 |
Completed |
Sanofi |
2015-11-30 |
| NCT01826760 |
Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure |
https://ClinicalTrials.gov/show/NCT01826760 |
Completed |
Wenzhou Medical University |
2010-05-31 |
| NCT01810835 |
Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. |
https://ClinicalTrials.gov/show/NCT01810835 |
Completed |
Hopital Lariboisière |
2013-11-30 |
| NCT01796457 |
HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01796457 |
Active, not recruiting |
University of Pennsylvania |
2020-07-31 |
| NCT03579576 |
Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar |
https://ClinicalTrials.gov/show/NCT03579576 |
Completed |
Right to Care |
2019-03-30 |
| NCT01782794 |
Acceptability of Hepatitis B Vaccination in General Population |
https://ClinicalTrials.gov/show/NCT01782794 |
Completed |
GlaxoSmithKline |
2012-06-30 |
| NCT01777074 |
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians |
https://ClinicalTrials.gov/show/NCT01777074 |
Completed |
GlaxoSmithKline |
2012-04-30 |
| NCT01772121 |
Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India |
https://ClinicalTrials.gov/show/NCT01772121 |
Completed |
Gilead Sciences |
2012-10-31 |
| NCT01771653 |
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT01771653 |
Completed |
Southern Illinois University |
2015-07-31 |
| NCT01766895 |
Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan |
https://ClinicalTrials.gov/show/NCT01766895 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2021-01-31 |
| NCT01750216 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 |
https://ClinicalTrials.gov/show/NCT01750216 |
Completed |
Hoffmann-La Roche |
2015-01-31 |
| NCT01732354 |
Study for Consolidation Period of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01732354 |
Completed |
Tainan Municipal Hospital |
2013-11-20 |
| NCT01732081 |
“Real-life” Cohort of Patients With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT01732081 |
Recruiting |
University Hospital, Strasbourg, France |
2021-01-31 |
| NCT01730508 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01730508 |
Completed |
Hoffmann-La Roche |
2017-06-25 |
| NCT03350074 |
HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT03350074 |
Completed |
Central Hospital, Nancy, France |
2016-05-01 |
| NCT01726400 |
In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia |
https://ClinicalTrials.gov/show/NCT01726400 |
Completed |
Fremantle Hospital and Health Service |
2014-01-31 |
| NCT01711164 |
The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis |
https://ClinicalTrials.gov/show/NCT01711164 |
Completed |
University Health Network, Toronto |
2016-05-31 |
| NCT01705717 |
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01705717 |
Completed |
Hoffmann-La Roche |
2012-05-01 |
| NCT01705704 |
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01705704 |
Completed |
Hoffmann-La Roche |
2013-02-28 |
| NCT01679834 |
An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01679834 |
Completed |
Hoffmann-La Roche |
2017-07-14 |
| NCT01671046 |
An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT01671046 |
Completed |
Hoffmann-La Roche |
2015-12-31 |
| NCT01667081 |
Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017) |
https://ClinicalTrials.gov/show/NCT01667081 |
Enrolling by invitation |
Merck Sharp & Dohme Corp. |
2021-05-24 |
| NCT01667432 |
An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01667432 |
Completed |
Hoffmann-La Roche |
2014-08-12 |
| NCT01659567 |
A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C |
https://ClinicalTrials.gov/show/NCT01659567 |
Completed |
Hoffmann-La Roche |
2015-10-20 |
| NCT01645969 |
A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265 |
https://ClinicalTrials.gov/show/NCT01645969 |
Completed |
Hoffmann-La Roche |
2012-10-31 |
| NCT01634919 |
Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated With Peginterferon Alpha-2a and Ribavirin |
https://ClinicalTrials.gov/show/NCT01634919 |
Completed |
Seoul National University Boramae Hospital |
2017-02-17 |
| NCT01623778 |
Optimization of Antiviral Therapy of Chronic HBV Infection |
https://ClinicalTrials.gov/show/NCT01623778 |
Completed |
Changhai Hospital |
2011-12-31 |
| NCT01609049 |
An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01609049 |
Completed |
Hoffmann-La Roche |
2015-06-22 |
| NCT01604291 |
An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01604291 |
Completed |
Hoffmann-La Roche |
2016-02-10 |
| NCT01577069 |
Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir |
https://ClinicalTrials.gov/show/NCT01577069 |
Completed |
Association HGE CHU Bordeaux Sud |
2013-01-31 |
| NCT01574521 |
Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT01574521 |
Completed |
Taizhou Hospital |
2010-12-31 |
| NCT01534728 |
Identification of Hepatitis C Virus (HCV) Specific T Cells |
https://ClinicalTrials.gov/show/NCT01534728 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2014-03-31 |
| NCT01544582 |
Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518) |
https://ClinicalTrials.gov/show/NCT01544582 |
Completed |
Merck Sharp & Dohme Corp. |
2015-07-31 |
| NCT01531166 |
A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon |
https://ClinicalTrials.gov/show/NCT01531166 |
Completed |
Yonsei University |
2014-08-31 |
| NCT01525810 |
Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial |
https://ClinicalTrials.gov/show/NCT01525810 |
Completed |
Bristol-Myers Squibb |
2014-11-30 |
| NCT01508130 |
An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 |
https://ClinicalTrials.gov/show/NCT01508130 |
Completed |
Hoffmann-La Roche |
2014-03-31 |
| NCT01502397 |
Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study |
https://ClinicalTrials.gov/show/NCT01502397 |
Completed |
The University of Hong Kong |
2015-12-31 |
| NCT01500265 |
Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus |
https://ClinicalTrials.gov/show/NCT01500265 |
Completed |
University Hospital, Limoges |
2013-12-31 |
| NCT01492504 |
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial |
https://ClinicalTrials.gov/show/NCT01492504 |
Completed |
Bristol-Myers Squibb |
2018-03-16 |
| NCT01481649 |
Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure |
https://ClinicalTrials.gov/show/NCT01481649 |
Completed |
The University of Hong Kong |
2015-02-28 |
| NCT01476995 |
Prognostic Indicators as Provided by the EPIC ClearView |
https://ClinicalTrials.gov/show/NCT01476995 |
Completed |
Epic Research & Diagnostics, Inc. |
2011-06-30 |
| NCT01474811 |
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network |
https://ClinicalTrials.gov/show/NCT01474811 |
Recruiting |
University of North Carolina, Chapel Hill |
2020-12-31 |
| NCT01464008 |
The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01464008 |
Completed |
Beijing Ditan Hospital |
2011-05-31 |
| NCT01457768 |
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response |
https://ClinicalTrials.gov/show/NCT01457768 |
Completed |
Gilead Sciences |
2018-04-09 |
| NCT01457755 |
Gilead Sustained Virologic Response (SVR) Registry |
https://ClinicalTrials.gov/show/NCT01457755 |
Completed |
Gilead Sciences |
2017-03-28 |
| NCT01453244 |
Pharmacogenomic Research in Korean Patients With Hepatitis C |
https://ClinicalTrials.gov/show/NCT01453244 |
Completed |
Inje University |
2013-03-31 |
| NCT01448915 |
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs) |
https://ClinicalTrials.gov/show/NCT01448915 |
Active, not recruiting |
Johns Hopkins University |
2021-04-30 |
| NCT01447680 |
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing |
https://ClinicalTrials.gov/show/NCT01447680 |
Completed |
G & W Laboratories Inc. |
2012-12-31 |
| NCT01447446 |
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01447446 |
Completed |
Hoffmann-La Roche |
2015-07-31 |
| NCT01429155 |
Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B |
https://ClinicalTrials.gov/show/NCT01429155 |
Completed |
Henry Ford Health System |
2013-01-31 |
| NCT01413490 |
Hepatitis C Rimantadine and Antiviral Combination Therapy |
https://ClinicalTrials.gov/show/NCT01413490 |
Completed |
The Leeds Teaching Hospitals NHS Trust |
2015-03-31 |
| NCT01402583 |
Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01402583 |
Completed |
University of Modena and Reggio Emilia |
2011-08-31 |
| NCT01401400 |
Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study |
https://ClinicalTrials.gov/show/NCT01401400 |
Completed |
Foundation for Liver Research |
2015-06-30 |
| NCT01405183 |
Association Between Hepatitis C Infection and Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01405183 |
Completed |
Henry Ford Health System |
2013-08-31 |
| NCT01392742 |
An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin |
https://ClinicalTrials.gov/show/NCT01392742 |
Completed |
Hoffmann-La Roche |
2014-07-31 |
| NCT01356901 |
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01356901 |
Completed |
Bristol-Myers Squibb |
2015-01-31 |
| NCT01353989 |
Hepatitis A Vaccination in the Elderly |
https://ClinicalTrials.gov/show/NCT01353989 |
Completed |
Rijnstate Hospital |
2015-07-31 |
| NCT01344889 |
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C) |
https://ClinicalTrials.gov/show/NCT01344889 |
Completed |
Hoffmann-La Roche |
2013-06-30 |
| NCT01323452 |
Entecavir for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01323452 |
Completed |
Foundation for Liver Research |
2011-01-31 |
| NCT04389268 |
P300 in Early Cognitive Impairment in Hepatitis C Virus |
https://ClinicalTrials.gov/show/NCT04389268 |
Completed |
Mansoura University Hospital |
2019-01-01 |
| NCT04371276 |
Seroepidemiology of Viral Hepatitis in Hong Kong |
https://ClinicalTrials.gov/show/NCT04371276 |
Enrolling by invitation |
Chinese University of Hong Kong |
2020-07-31 |
| NCT04330508 |
Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial |
https://ClinicalTrials.gov/show/NCT04330508 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-10-31 |
| NCT04352309 |
Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT04352309 |
Recruiting |
AbbVie |
2021-04-20 |
| NCT04310787 |
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT04310787 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2020-08-15 |
| NCT04264312 |
Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria |
https://ClinicalTrials.gov/show/NCT04264312 |
Completed |
Centers for Disease Control and Prevention, China |
2019-09-28 |
| NCT04247490 |
Autoimmune Hepatitis in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT04247490 |
Completed |
University Hospital of Ferrara |
2019-12-31 |
| NCT04234139 |
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation |
https://ClinicalTrials.gov/show/NCT04234139 |
Enrolling by invitation |
Johns Hopkins University |
2025-12-31 |
| NCT04214028 |
A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus |
https://ClinicalTrials.gov/show/NCT04214028 |
Recruiting |
AbbVie |
2024-12-30 |
| NCT04211805 |
Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B |
https://ClinicalTrials.gov/show/NCT04211805 |
Recruiting |
New Discovery LLC |
2021-09-30 |
| NCT04208035 |
Hepatitis C Elimination in the Netherlands |
https://ClinicalTrials.gov/show/NCT04208035 |
Recruiting |
Radboud University |
2021-01-01 |
| NCT04189627 |
A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation |
https://ClinicalTrials.gov/show/NCT04189627 |
Recruiting |
AbbVie |
2021-03-01 |
| NCT04170452 |
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta |
https://ClinicalTrials.gov/show/NCT04170452 |
Enrolling by invitation |
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan |
2020-06-01 |
| NCT04160897 |
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04160897 |
Enrolling by invitation |
Ruijin Hospital |
2020-10-31 |
| NCT02786758 |
Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals |
https://ClinicalTrials.gov/show/NCT02786758 |
Completed |
Macfarlane Burnet Institute for Medical Research and Public Health Ltd |
2019-07-31 |
| NCT04135235 |
Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B |
https://ClinicalTrials.gov/show/NCT04135235 |
Recruiting |
Beijing Ditan Hospital |
2021-08-01 |
| NCT04103840 |
Invasive Fungal Infections in Severe Alcohol-associated Hepatitis |
https://ClinicalTrials.gov/show/NCT04103840 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2022-10-01 |
| NCT04090164 |
Association of Hepatitis C Virus With Breast Cancer |
https://ClinicalTrials.gov/show/NCT04090164 |
Active, not recruiting |
Mansoura University |
2020-06-30 |
| NCT04094272 |
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT04094272 |
Completed |
Kantonsspital Olten |
2019-05-01 |
| NCT04071353 |
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT04071353 |
Recruiting |
Beijing Ditan Hospital |
2020-08-01 |
| NCT04057001 |
Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study |
https://ClinicalTrials.gov/show/NCT04057001 |
Recruiting |
Yale University |
2020-06-30 |
| NCT04047680 |
eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs |
https://ClinicalTrials.gov/show/NCT04047680 |
Completed |
National Taiwan University Hospital |
2018-12-31 |
| NCT04038320 |
Simplified Antiviral Treatment Strategy for Hepatitis C in Ukraine |
https://ClinicalTrials.gov/show/NCT04038320 |
Completed |
Right to Care |
2019-03-30 |
| NCT04028856 |
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04028856 |
Completed |
Beijing Ditan Hospital |
2019-06-30 |
| NCT03993925 |
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong |
https://ClinicalTrials.gov/show/NCT03993925 |
Recruiting |
The University of Hong Kong |
2020-09-30 |
| NCT03980301 |
Screening Hepatitis Positive Women for Congenital Anomalies |
https://ClinicalTrials.gov/show/NCT03980301 |
Recruiting |
Aljazeera Hospital |
2020-06-15 |
| NCT03979053 |
Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis. |
https://ClinicalTrials.gov/show/NCT03979053 |
Completed |
Perspectum Diagnostics Ltd |
2019-10-31 |
| NCT03977857 |
Computed Tomography Liver Volume for Predicting Short-term Mortality in Hepatitis Bâ€Acuteâ€onâ€Chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT03977857 |
Completed |
First Affiliated Hospital Xi’an Jiaotong University |
2019-12-31 |
| NCT03977987 |
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission |
https://ClinicalTrials.gov/show/NCT03977987 |
Completed |
Huashan Hospital |
2018-12-30 |
| NCT03908294 |
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents |
https://ClinicalTrials.gov/show/NCT03908294 |
Completed |
Johann Wolfgang Goethe University Hospital |
2020-01-01 |
| NCT03880682 |
Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT03880682 |
Completed |
Istanbul University |
2019-06-15 |
| NCT03868163 |
Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation |
https://ClinicalTrials.gov/show/NCT03868163 |
Active, not recruiting |
AbbVie |
2020-08-15 |
| NCT03864263 |
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents |
https://ClinicalTrials.gov/show/NCT03864263 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2020-12-31 |
| NCT03865966 |
Hepatitis B Virus Infection After Liver Transplantation in Children |
https://ClinicalTrials.gov/show/NCT03865966 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2023-12-31 |
| NCT03850899 |
Alcoholic Hepatitis Network Observational Study |
https://ClinicalTrials.gov/show/NCT03850899 |
Recruiting |
Indiana University |
2024-02-29 |
| NCT03839979 |
HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt |
https://ClinicalTrials.gov/show/NCT03839979 |
Completed |
Cairo University |
2018-12-31 |
| NCT03777969 |
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03777969 |
Recruiting |
Beijing Friendship Hospital |
2020-12-31 |
| NCT03776760 |
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination |
https://ClinicalTrials.gov/show/NCT03776760 |
Recruiting |
Kirby Institute |
2022-02-28 |
| NCT03740906 |
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting |
https://ClinicalTrials.gov/show/NCT03740906 |
Recruiting |
Kirby Institute |
2021-01-31 |
| NCT03743272 |
Repeatability and Reproducibility of Multiparametric MRI |
https://ClinicalTrials.gov/show/NCT03743272 |
Recruiting |
Perspectum Diagnostics Ltd |
2020-05-17 |
| NCT03740230 |
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs |
https://ClinicalTrials.gov/show/NCT03740230 |
Recruiting |
AbbVie |
2022-09-30 |
| NCT03711669 |
Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis |
https://ClinicalTrials.gov/show/NCT03711669 |
Recruiting |
Hospital Clinic of Barcelona |
2021-01-31 |
| NCT03702998 |
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population |
https://ClinicalTrials.gov/show/NCT03702998 |
Recruiting |
Chinese University of Hong Kong |
2020-07-31 |
| NCT03697135 |
Ask a Friend to Take a Test for Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT03697135 |
Enrolling by invitation |
NHS Tayside |
2019-12-30 |
| NCT03692897 |
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection |
https://ClinicalTrials.gov/show/NCT03692897 |
Active, not recruiting |
Target PharmaSolutions, Inc. |
2023-01-31 |
| NCT03693586 |
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis |
https://ClinicalTrials.gov/show/NCT03693586 |
Recruiting |
Hospital General de Mexico |
2020-05-01 |
| NCT03640728 |
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT03640728 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-04-30 |
| NCT03601221 |
Seroprevalence Hepatitis E Infection in Healthy Blood Donors |
https://ClinicalTrials.gov/show/NCT03601221 |
Completed |
Ente Ospedaliero Cantonale, Bellinzona |
2018-12-31 |
| NCT03570112 |
Transmission of Chronic Hepatitis C in Pregnancy |
https://ClinicalTrials.gov/show/NCT03570112 |
Recruiting |
The Christ Hospital |
2020-06-30 |
| NCT03559790 |
Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea |
https://ClinicalTrials.gov/show/NCT03559790 |
Recruiting |
The Catholic University of Korea |
2020-08-31 |
| NCT03564639 |
Examining Hepatitis C Reinfection Rates in Kenya |
https://ClinicalTrials.gov/show/NCT03564639 |
Enrolling by invitation |
Yale University |
2020-11-30 |
| NCT03551002 |
Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego |
https://ClinicalTrials.gov/show/NCT03551002 |
Recruiting |
University of California, San Diego |
2020-12-31 |
| NCT03529760 |
Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia |
https://ClinicalTrials.gov/show/NCT03529760 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2019-07-15 |
| NCT03524014 |
Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms. |
https://ClinicalTrials.gov/show/NCT03524014 |
Recruiting |
Central Hospital, Nancy, France |
2019-06-30 |
| NCT03511794 |
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03511794 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
2021-06-01 |
| NCT03500562 |
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC) |
https://ClinicalTrials.gov/show/NCT03500562 |
Recruiting |
Bristol-Myers Squibb |
2021-12-31 |
| NCT03459768 |
Cohort Study on People Who Inject Drugs in Senegal |
https://ClinicalTrials.gov/show/NCT03459768 |
Active, not recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2020-02-29 |
| NCT03425513 |
Hepatitis B Virus Prevalence and Risk Factors in Belgium |
https://ClinicalTrials.gov/show/NCT03425513 |
Completed |
Hasselt University |
2017-11-27 |
| NCT03426618 |
A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03426618 |
Completed |
Bristol-Myers Squibb |
2019-03-13 |
| NCT03423641 |
An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C |
https://ClinicalTrials.gov/show/NCT03423641 |
Completed |
Kaiser Permanente |
2017-12-31 |
| NCT03415009 |
Prevalence of IL28B Polymorphism in Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT03415009 |
Completed |
Changi General Hospital |
2016-06-30 |
| NCT03413696 |
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients |
https://ClinicalTrials.gov/show/NCT03413696 |
Enrolling by invitation |
University of California, San Diego |
2019-12-31 |
| NCT01264107 |
An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine |
https://ClinicalTrials.gov/show/NCT01264107 |
Completed |
Bukwang Pharmaceutical |
2012-01-31 |
| NCT01245257 |
Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT01245257 |
Completed |
University of Aarhus |
2015-06-30 |
| NCT01200225 |
An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) |
https://ClinicalTrials.gov/show/NCT01200225 |
Completed |
Hoffmann-La Roche |
2013-06-30 |
| NCT01163240 |
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01163240 |
Completed |
Novartis |
2011-09-30 |
| NCT01160081 |
Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis |
https://ClinicalTrials.gov/show/NCT01160081 |
Completed |
GlaxoSmithKline |
2010-09-30 |
| NCT01155427 |
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT01155427 |
Completed |
Bristol-Myers Squibb |
2010-04-30 |
| NCT01159951 |
Analysis of Trends Over Time of Hepatitis Related Incidence in Panama |
https://ClinicalTrials.gov/show/NCT01159951 |
Completed |
GlaxoSmithKline |
2011-08-31 |
| NCT01159925 |
Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children |
https://ClinicalTrials.gov/show/NCT01159925 |
Completed |
GlaxoSmithKline |
2011-12-31 |
| NCT01159613 |
Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection? |
https://ClinicalTrials.gov/show/NCT01159613 |
Completed |
Ziv Hospital |
2008-10-31 |
| NCT01128686 |
Lamivudine(LAM) Good Responder Study |
https://ClinicalTrials.gov/show/NCT01128686 |
Completed |
ViiV Healthcare |
2011-06-30 |
| NCT01107483 |
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT01107483 |
Completed |
Sun Yat-sen University |
2010-02-28 |
| NCT01112033 |
Biliverdin Reductase A in Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01112033 |
Completed |
Charles University, Czech Republic |
2013-03-31 |
| NCT01098097 |
Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011) |
https://ClinicalTrials.gov/show/NCT01098097 |
Completed |
Merck Sharp & Dohme Corp. |
2011-10-31 |
| NCT01090531 |
Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT01090531 |
Active, not recruiting |
Johann Wolfgang Goethe University Hospital |
2021-08-31 |
| NCT01066819 |
PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b |
https://ClinicalTrials.gov/show/NCT01066819 |
Completed |
Hoffmann-La Roche |
2011-08-31 |
| NCT01070550 |
PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a) |
https://ClinicalTrials.gov/show/NCT01070550 |
Completed |
Hoffmann-La Roche |
2011-07-31 |
| NCT01066793 |
PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b |
https://ClinicalTrials.gov/show/NCT01066793 |
Completed |
Hoffmann-La Roche |
2011-03-31 |
| NCT01062321 |
Role of Cytokines in Hepatitis E Virus Infection During Pregnancy |
https://ClinicalTrials.gov/show/NCT01062321 |
Completed |
Maulana Azad Medical College |
2012-07-31 |
| NCT01054742 |
Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2) |
https://ClinicalTrials.gov/show/NCT01054742 |
Completed |
Merck Sharp & Dohme Corp. |
2011-06-30 |
| NCT01033045 |
Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure |
https://ClinicalTrials.gov/show/NCT01033045 |
Completed |
Fundacion IMIM |
2013-07-31 |
| NCT01011738 |
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys |
https://ClinicalTrials.gov/show/NCT01011738 |
Completed |
Hoffmann-La Roche |
2014-11-18 |
| NCT00998621 |
ADHEPTA Study: Adherence Questionnaire in Hepatitis C |
https://ClinicalTrials.gov/show/NCT00998621 |
Completed |
Fundacion IMIM |
2010-09-30 |
| NCT00979979 |
Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test |
https://ClinicalTrials.gov/show/NCT00979979 |
Completed |
National Taiwan University Hospital |
2013-10-31 |
| NCT00970216 |
Study of Telbivudine in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00970216 |
Completed |
Chang Gung Memorial Hospital |
2016-01-31 |
| NCT00946010 |
Investigation of Hepatitis B and Hepatitis C in Taiwan |
https://ClinicalTrials.gov/show/NCT00946010 |
Completed |
National Taiwan University Hospital |
2010-08-31 |
| NCT00881036 |
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients |
https://ClinicalTrials.gov/show/NCT00881036 |
Completed |
Kyoto University |
2015-07-31 |
| NCT00876148 |
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting |
https://ClinicalTrials.gov/show/NCT00876148 |
Completed |
Azienda Ospedaliera San Giovanni Battista |
NA |
| NCT00863109 |
Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336) |
https://ClinicalTrials.gov/show/NCT00863109 |
Completed |
Merck Sharp & Dohme Corp. |
2013-05-31 |
| NCT04088370 |
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT04088370 |
Recruiting |
The Cleveland Clinic |
2021-09-30 |
| NCT01581554 |
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01581554 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04366973 |
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers |
https://ClinicalTrials.gov/show/NCT04366973 |
Recruiting |
AbbVie |
2022-09-30 |
| NCT04036760 |
Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City Jails |
https://ClinicalTrials.gov/show/NCT04036760 |
Completed |
NYU Langone Health |
2017-04-30 |
| NCT01416610 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy |
https://ClinicalTrials.gov/show/NCT01416610 |
Completed |
Hoffmann-La Roche |
2014-10-31 |
| NCT01957085 |
Undiagnosed Hepatitis C Infection in an Urban Hospital |
https://ClinicalTrials.gov/show/NCT01957085 |
Completed |
Temple University |
2015-12-31 |
| NCT02005146 |
Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs |
https://ClinicalTrials.gov/show/NCT02005146 |
Completed |
Andalusian Network for Design and Translation of Advanced Therapies |
2014-12-31 |
| NCT01337479 |
A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials |
https://ClinicalTrials.gov/show/NCT01337479 |
Completed |
Bristol-Myers Squibb |
2010-09-30 |
| NCT01182311 |
Duration of Long-term Immunity After Hepatitis B Virus Immunization |
https://ClinicalTrials.gov/show/NCT01182311 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03510637 |
“Real Life” Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt |
https://ClinicalTrials.gov/show/NCT03510637 |
Recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2020-08-31 |
| NCT02850289 |
APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin |
https://ClinicalTrials.gov/show/NCT02850289 |
Completed |
Hoffmann-La Roche |
2008-10-31 |
| NCT02581163 |
Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium |
https://ClinicalTrials.gov/show/NCT02581163 |
Completed |
AbbVie |
2018-02-12 |
| NCT02581020 |
The Durability of Response and Persistence of Resistance to AbbVie’s 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT02581020 |
Active, not recruiting |
AbbVie |
2020-12-31 |
| NCT02515279 |
An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria |
https://ClinicalTrials.gov/show/NCT02515279 |
Completed |
Hoffmann-La Roche |
2014-12-31 |
| NCT02443233 |
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong |
https://ClinicalTrials.gov/show/NCT02443233 |
Completed |
The University of Hong Kong |
2016-12-31 |
| NCT01959321 |
An Observational Study of Hepatitis C Virus in Pregnancy |
https://ClinicalTrials.gov/show/NCT01959321 |
Active, not recruiting |
The George Washington University Biostatistics Center |
2020-12-31 |
| NCT01734018 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01734018 |
Completed |
Hoffmann-La Roche |
2012-08-31 |
| NCT03181113 |
Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy |
https://ClinicalTrials.gov/show/NCT03181113 |
Enrolling by invitation |
Xiamen Amoytop Biotech Co., Ltd. |
2020-12-31 |
| NCT00913757 |
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area |
https://ClinicalTrials.gov/show/NCT00913757 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-05-01 |
| NCT00782158 |
Hepatitis B and HIV Co-Infection in Patients in Uganda |
https://ClinicalTrials.gov/show/NCT00782158 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00769730 |
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication |
https://ClinicalTrials.gov/show/NCT00769730 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2009-02-28 |
| NCT00736242 |
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584) |
https://ClinicalTrials.gov/show/NCT00736242 |
Completed |
Merck Sharp & Dohme Corp. |
2011-12-31 |
| NCT00727311 |
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00727311 |
Completed |
Merck Sharp & Dohme Corp. |
2009-06-30 |
| NCT00728494 |
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) |
https://ClinicalTrials.gov/show/NCT00728494 |
Completed |
Merck Sharp & Dohme Corp. |
2007-12-31 |
| NCT00725751 |
Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255) |
https://ClinicalTrials.gov/show/NCT00725751 |
Completed |
Merck Sharp & Dohme Corp. |
2011-03-31 |
| NCT00726557 |
Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261) |
https://ClinicalTrials.gov/show/NCT00726557 |
Completed |
Merck Sharp & Dohme Corp. |
2009-01-31 |
| NCT00725205 |
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690) |
https://ClinicalTrials.gov/show/NCT00725205 |
Completed |
Merck Sharp & Dohme Corp. |
2010-10-31 |
| NCT00724893 |
Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423) |
https://ClinicalTrials.gov/show/NCT00724893 |
Completed |
Merck Sharp & Dohme Corp. |
2012-08-31 |
| NCT00724854 |
Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427) |
https://ClinicalTrials.gov/show/NCT00724854 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-30 |
| NCT00724295 |
Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505) |
https://ClinicalTrials.gov/show/NCT00724295 |
Completed |
Merck Sharp & Dohme Corp. |
2008-12-31 |
| NCT00724464 |
Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209) |
https://ClinicalTrials.gov/show/NCT00724464 |
Completed |
Merck Sharp & Dohme Corp. |
2010-10-31 |
| NCT00724230 |
Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00724230 |
Completed |
Merck Sharp & Dohme Corp. |
2008-12-31 |
| NCT00724451 |
Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1) |
https://ClinicalTrials.gov/show/NCT00724451 |
Completed |
Merck Sharp & Dohme Corp. |
2011-10-31 |
| NCT00723892 |
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252) |
https://ClinicalTrials.gov/show/NCT00723892 |
Completed |
Merck Sharp & Dohme Corp. |
2009-05-31 |
| NCT00723632 |
Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00723632 |
Completed |
Merck Sharp & Dohme Corp. |
2010-12-31 |
| NCT00710801 |
Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation |
https://ClinicalTrials.gov/show/NCT00710801 |
Completed |
University of Alberta |
NA |
| NCT00709228 |
Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793) |
https://ClinicalTrials.gov/show/NCT00709228 |
Completed |
Merck Sharp & Dohme Corp. |
2008-11-30 |
| NCT00709059 |
Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243) |
https://ClinicalTrials.gov/show/NCT00709059 |
Completed |
Merck Sharp & Dohme Corp. |
2009-12-31 |
| NCT00705666 |
Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00705666 |
Completed |
Merck Sharp & Dohme Corp. |
2008-07-31 |
| NCT00707603 |
Chronic Hepatitis C and Insulin Resistance |
https://ClinicalTrials.gov/show/NCT00707603 |
Completed |
Garvan Institute of Medical Research |
2008-12-31 |
| NCT00705263 |
Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00705263 |
Completed |
Schering-Plough |
2008-05-31 |
| NCT00704964 |
Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413) |
https://ClinicalTrials.gov/show/NCT00704964 |
Completed |
Merck Sharp & Dohme Corp. |
2009-10-31 |
| NCT00705224 |
Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562) |
https://ClinicalTrials.gov/show/NCT00705224 |
Completed |
Merck Sharp & Dohme Corp. |
2010-08-31 |
| NCT00704717 |
Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301) |
https://ClinicalTrials.gov/show/NCT00704717 |
Completed |
Merck Sharp & Dohme Corp. |
2007-12-31 |
| NCT00704522 |
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00704522 |
Completed |
Merck Sharp & Dohme Corp. |
2009-04-30 |
| NCT00703560 |
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients |
https://ClinicalTrials.gov/show/NCT00703560 |
Completed |
University of Texas Southwestern Medical Center |
2011-09-30 |
| NCT00700401 |
POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin). |
https://ClinicalTrials.gov/show/NCT00700401 |
Completed |
Hoffmann-La Roche |
2010-11-30 |
| NCT00674492 |
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal |
https://ClinicalTrials.gov/show/NCT00674492 |
Completed |
VA Office of Research and Development |
2008-08-31 |
| NCT00659256 |
Hepatitis C Treatment and Atherosclerosis |
https://ClinicalTrials.gov/show/NCT00659256 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00645736 |
CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study |
https://ClinicalTrials.gov/show/NCT00645736 |
Completed |
Gilead Sciences |
2008-10-31 |
| NCT00606528 |
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT00606528 |
Completed |
University Health Network, Toronto |
2013-07-31 |
| NCT00527774 |
Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients |
https://ClinicalTrials.gov/show/NCT00527774 |
Completed |
St. Martin De Porress Hospital |
2008-02-29 |
| NCT00512941 |
Laboratory Profile of Hepatitis B and C in Users of a Reference Service |
https://ClinicalTrials.gov/show/NCT00512941 |
Completed |
UPECLIN HC FM Botucatu Unesp |
NA |
| NCT00514111 |
Factors Associated to Success of Hepatitis C Therapy |
https://ClinicalTrials.gov/show/NCT00514111 |
Completed |
UPECLIN HC FM Botucatu Unesp |
2008-07-31 |
| NCT00494936 |
Effects of HIV and Hepatitis C Virus on the Brain |
https://ClinicalTrials.gov/show/NCT00494936 |
Completed |
Icahn School of Medicine at Mount Sinai |
2009-07-31 |
| NCT00473993 |
Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland |
https://ClinicalTrials.gov/show/NCT00473993 |
Completed |
Seidenberg, Arztpraxis A., M.D. |
NA |
| NCT00466336 |
Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices |
https://ClinicalTrials.gov/show/NCT00466336 |
Completed |
National Taiwan University Hospital |
2006-12-31 |
| NCT00444002 |
Oxidative Stress and Fatty Acids in Hepatitis C |
https://ClinicalTrials.gov/show/NCT00444002 |
Completed |
University Health Network, Toronto |
2008-07-31 |
| NCT00422838 |
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. |
https://ClinicalTrials.gov/show/NCT00422838 |
Completed |
Foundation for Liver Research |
2010-06-30 |
| NCT00388674 |
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT00388674 |
Completed |
Bristol-Myers Squibb |
2016-10-26 |
| NCT00381992 |
Risk Assessment of Long-Haul Truck Drivers |
https://ClinicalTrials.gov/show/NCT00381992 |
Completed |
Wake Forest University Health Sciences |
2010-03-31 |
| NCT00342641 |
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers |
https://ClinicalTrials.gov/show/NCT00342641 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00368225 |
Transplant-Related Accelerated Progression of Hepatitis C |
https://ClinicalTrials.gov/show/NCT00368225 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00361179 |
Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00361179 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00348660 |
Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic |
https://ClinicalTrials.gov/show/NCT00348660 |
Completed |
St. Michael’s Hospital, Toronto |
2010-10-31 |
| NCT00342186 |
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus |
https://ClinicalTrials.gov/show/NCT00342186 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-02-22 |
| NCT00322179 |
Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00322179 |
Completed |
Palo Alto Veterans Institute for Research |
2007-11-30 |
| NCT00237991 |
Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population |
https://ClinicalTrials.gov/show/NCT00237991 |
Completed |
GlaxoSmithKline |
NA |
| NCT00237432 |
Study of the Immune Response to Hepatitis C Virus |
https://ClinicalTrials.gov/show/NCT00237432 |
Completed |
Rockefeller University |
NA |
| NCT00227149 |
Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00227149 |
Completed |
University of Wuerzburg |
NA |
| NCT00219999 |
Hepatitis C Virus and the Humoral Immune System |
https://ClinicalTrials.gov/show/NCT00219999 |
Completed |
Rockefeller University |
2013-05-31 |
| NCT00216775 |
Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00216775 |
Completed |
Kyoto University |
2008-05-31 |
| NCT00205075 |
Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression |
https://ClinicalTrials.gov/show/NCT00205075 |
Completed |
University of Wisconsin, Madison |
2008-06-30 |
| NCT00199732 |
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a |
https://ClinicalTrials.gov/show/NCT00199732 |
Completed |
University Hospital, Limoges |
2009-07-31 |
| NCT00187473 |
Natural History of Hepatitis C in Patients With Normal Liver Tests |
https://ClinicalTrials.gov/show/NCT00187473 |
Active, not recruiting |
University of California, San Francisco |
2020-12-31 |
| NCT00168194 |
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History |
https://ClinicalTrials.gov/show/NCT00168194 |
Completed |
The Alfred |
NA |
| NCT00158717 |
Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. |
https://ClinicalTrials.gov/show/NCT00158717 |
Completed |
Gilead Sciences |
2006-04-30 |
| NCT00155155 |
Studies of Immune Responses in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00155155 |
Completed |
National Taiwan University Hospital |
2008-04-30 |
| NCT00150904 |
Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP) |
https://ClinicalTrials.gov/show/NCT00150904 |
Completed |
UMC Utrecht |
2008-09-30 |
| NCT00142740 |
Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 |
https://ClinicalTrials.gov/show/NCT00142740 |
Completed |
University of North Carolina, Chapel Hill |
2008-06-30 |
| NCT00141999 |
Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT00141999 |
Completed |
Centers for Disease Control and Prevention |
2005-03-31 |
| NCT00136214 |
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects |
https://ClinicalTrials.gov/show/NCT00136214 |
Completed |
Beth Israel Deaconess Medical Center |
2008-01-31 |
| NCT00097006 |
Retrovirus Epidemiology Donor Study-II (REDS-II) |
https://ClinicalTrials.gov/show/NCT00097006 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-09-30 |
| NCT00076427 |
Leukapheresis for Research on HCV-Coinfected Patients |
https://ClinicalTrials.gov/show/NCT00076427 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00071916 |
Racial Difference in HCV/Host Interactions |
https://ClinicalTrials.gov/show/NCT00071916 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00819026 |
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors |
https://ClinicalTrials.gov/show/NCT00819026 |
Completed |
University of Wisconsin, Madison |
2013-08-31 |
| NCT00059397 |
Hepatitis C: Grading and Staging by MR |
https://ClinicalTrials.gov/show/NCT00059397 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00059267 |
Prevention of Recurrent Hepatitis B After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00059267 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2007-11-30 |
| NCT00001879 |
Collections of Blood and Stool Samples in Patients With Acute Hepatitis |
https://ClinicalTrials.gov/show/NCT00001879 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004848 |
A Controlled Prospective Study of Transfusion-Associated Hepatitis |
https://ClinicalTrials.gov/show/NCT00004848 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001982 |
History of Hepatitis C in Volunteer Blood Donors |
https://ClinicalTrials.gov/show/NCT00001982 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037076 |
Prevalence of Hepatitis C Virus Infection in HIV-Infected Children |
https://ClinicalTrials.gov/show/NCT00037076 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00727259 |
Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067) |
https://ClinicalTrials.gov/show/NCT00727259 |
Completed |
Merck Sharp & Dohme Corp. |
2008-04-30 |
| NCT00006643 |
Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus |
https://ClinicalTrials.gov/show/NCT00006643 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001117 |
A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT00001117 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00723645 |
Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181) |
https://ClinicalTrials.gov/show/NCT00723645 |
Completed |
Merck Sharp & Dohme Corp. |
2010-04-30 |
| NCT00006301 |
Immune Response to Hepatitis C Virus |
https://ClinicalTrials.gov/show/NCT00006301 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00007709 |
To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI). |
https://ClinicalTrials.gov/show/NCT00007709 |
Completed |
VA Office of Research and Development |
NA |
| NCT00007371 |
Hepatitis C in Clinically Discordant Hemophilic Siblings |
https://ClinicalTrials.gov/show/NCT00007371 |
Completed |
University of North Carolina, Chapel Hill |
2004-08-31 |
| NCT00005306 |
Natural History of Post-transfusion Non-A, Non-B Hepatitis |
https://ClinicalTrials.gov/show/NCT00005306 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005339 |
Risk of Post Transfusion Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00005339 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005305 |
Hepatitis Delta Infections in Hemophiliacs |
https://ClinicalTrials.gov/show/NCT00005305 |
Completed |
University of North Carolina, Chapel Hill |
1991-09-30 |
| NCT00005657 |
Genetics of Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00005657 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00005304 |
Delta Hepatitis and Liver Disease in Hemophiliacs |
https://ClinicalTrials.gov/show/NCT00005304 |
Completed |
Baylor College of Medicine |
NA |
| NCT00001712 |
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan |
https://ClinicalTrials.gov/show/NCT00001712 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |